Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors

• Asıl Yazarlar: Rita Nade (Yazar), Esther Tannoury (Yazar), Tamina Rizk (Yazar), Hady Ghanem (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: University of São Paulo, 2021-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Immune-mediated encephalitis as an adverse event due to checkpoint inhibitors is very rare. We describe herein the case of a 38-year-old woman with metastatic triple-negative breast cancer who developed seizures and somnolence twelve days after receiving the first dose of Atezolizumab. Work up ruled...